Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including β3-Adrenoceptor Agonists -Basic Research Perspectives-
International Neurourology Journal · 29.02.2024 · 28 (Suppl 1) · 12-33
DOI: 10.5213/inj.2448002.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Neurourology Journal, erschienen am 29.02.2024. Verfasst von Joonbeom Kwon und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 225 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NIH HHS, NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Overactive bladder (OAB) is a symptom-based syndrome defined by urinary urgency, frequency, and nocturia with or without urge incontinence. The causative pathology is diverse; including bladder outlet obstruction (BOO), bladder ischemia, aging, metabolic syndrome, psychological stress, affective disorder, urinary microbiome, localized and systemic inflammatory responses, etc. Several hypotheses have been suggested as mechanisms of OAB generation; among them, neurogenic, myogenic, and urothelial mechanisms are well-known hypotheses. Also, a series of local signals called autonomous myogenic contraction, micromotion, or afferent noises, which can occur during bladder filling, may be induced by the leak of acetylcholine (ACh) or urothelial release of adenosine triphosphate (ATP). They can be transmitted to the central nervous system through afferent fibers to trigger coordinated urgency-related detrusor contractions. Antimuscarinics, commonly known to induce smooth muscle relaxation by competitive blockage of muscarinic receptors in the parasympathetic postganglionic nerve, have a minimal effect on detrusor contraction within therapeutic doses. In fact, they have a predominant role in preventing signals in the afferent nerve transmission process. β3-adrenergic receptor (AR) agonists inhibit afferent signals by predominant inhibition of mechanosensitive Aδ-fibers in the normal bladder. However, in pathologic conditions such as spinal cord injury, it seems to inhibit capsaicin-sensitive C-fibers. Particularly, mirabegron, a β3-agonist, prevents ACh release in the BOO-induced detrusor overactivity model by parasympathetic prejunctional mechanisms. A recent study also revealed that vibegron may have 2 mechanisms of action: inhibition of ACh from cholinergic efferent nerves in the detrusor and afferent inhibition via urothelial β3-AR.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
- Leaders Urology Clinic, Daegu, Korea.
- Department of Urology, Catholic University of Daegu School of Medicine, Daegu, Korea.
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
- Department of Mechanical Engineering and Materials Science, University of Pittsburgh School of Bioengineering, Pittsburgh, PA, USA.
Förderung
- NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Kwon, J., Kim, D. Y., Cho, K. J., Hashimoto, M., Matsuoka, K., Kamijo, T., Wang, Z., Karnup, S., Robertson, A. M., Tyagi, P., & Yoshimura, N. (2024). Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including β3-Adrenoceptor Agonists -Basic Research Perspectives-. International Neurourology Journal, 28(Suppl 1), 12-33. https://doi.org/10.5213/inj.2448002.001
Vancouver
Kwon J, Kim DY, Cho KJ, Hashimoto M, Matsuoka K, Kamijo T, et al. Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including β3-Adrenoceptor Agonists -Basic Research Perspectives-. International Neurourology Journal. 2024;28(Suppl 1):12-33. doi:10.5213/inj.2448002.001
BibTeX
@article{Kwon2024,
author = {Kwon, Joonbeom and Kim, Duk Yoon and Cho, Kang Jun and Hashimoto, Mamoru and Matsuoka, Kanako and Kamijo, Tadanobu and Wang, Zhou and Karnup, Sergei and Robertson, Anne M and Tyagi, Pradeep and Yoshimura, Naoki},
title = {Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including β3-Adrenoceptor Agonists -Basic Research Perspectives-},
journal = {International Neurourology Journal},
year = {2024},
volume = {28},
number = {Suppl 1},
pages = {12--33},
doi = {10.5213/inj.2448002.001}
}
EUVIMED